No Data
No Data
Is Hyphens Pharma International Limited's (Catalist:1J5) Latest Stock Performance Being Led By Its Strong Fundamentals?
Singapore Shares Remain Flat Despite Overnight Gains in Global Markets; Zheneng Jinjiang Rises 3%
Singapore's Straits Times Index remained flat on Thursday despite overnight gains in the global markets led by technology stocks. During the day, the benchmark Singapore Strait Times Index ranged betw
Hyphens Pharma's Subsidiary Enters Exclusive Deal With Maruho
Hyphens Pharma (SGX:1J5) subsidiary, Hyphens Pharma Pte entered into an exclusive license, development and commercialization agreement with Maruho for the rights to register and commercialize Amenarel
Hyphens Pharma Subsidiary Enters Into Exclusive Licensing Agreement With Maruho for Shingles Medication
Hyphens Pharma Holds Insightful AGM
Hyphens Pharma International Reports First Quarter 2024 Earnings
No Data